Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group)

Creative Commons License

Erol C., Sakin A., BAŞOĞLU TÜYLÜ T., Ozden E., ÇABUK D., Dogan M., ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.52, sa.4, ss.1022-1032, 2022 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 52 Sayı: 4
  • Basım Tarihi: 2022
  • Doi Numarası: 10.55730/1300-0144.5404
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1022-1032
  • Anahtar Kelimeler: FLOT chemotherapy, perioperative treatment, gastric cancer, GEJ tumor, prognostic factor, NEUTROPHIL-LYMPHOCYTE RATIO, CHEMOTHERAPY, ADENOCARCINOMA, SURVIVAL, PLATELET, NOMOGRAM, SURGERY, CANCER
  • Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

Background/aim: Perioperative FLOT regimen is a standard of care in locally advanced operable gastric and GEJ adenocarcinoma. We aimed to determine the efficacy, prognostic factors of perioperative FLOT chemotherapy in real-life gastric and GEJ tumors.